Back to Journals » Cancer Management and Research » Volume 10

Overview of advances in vasculogenic mimicry – a potential target for tumor therapy

Authors Ge H, Luo H

Received 5 February 2018

Accepted for publication 30 March 2018

Published 2 August 2018 Volume 2018:10 Pages 2429—2437

DOI https://doi.org/10.2147/CMAR.S164675

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Justinn Cochran

Peer reviewer comments 2

Editor who approved publication: Professor Lu-Zhe Sun


Hong Ge,1 Hui Luo1,2

1Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China; 2Division of Graduate, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China

Abstract: Vasculogenic mimicry (VM) describes the process utilized by highly aggressive cancer cells to generate vascular-like structures without the presence of endothelial cells. VM has been vividly described in various tumors and participates in cancer progression dissemination and metastasis. Diverse molecular mechanisms and signaling pathways are involved in VM formation. Furthermore, the patterning characteristics of VM, detected with molecular imaging, are being investigated for use as a tool to aid clinical practice. This review explores the most recent studies investigating the role of VM in tumor induction. Indeed, the recognition of these advances will increasingly affect the development of novel therapeutic target strategies for VM in human cancer.

Keywords: vasculogenic mimicry, mechanisms, molecular imaging, clinical significance, target therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]